PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$6.92
Tradestie Score
65
Market Cap
$871.90M
Revenue Growth
0.9%
Analyst Upside
+195.6%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$14.74
|
$626.91M | - | 67 | Compare |
|
KROS
Keros Therapeutics, Inc. Common Stock
|
$11.36
|
$620.60M | - | 54 | Compare |
|
SVRA
Savara Inc.
|
$4.81
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.56
|
$552.46M | - | 46 | Compare |
|
VSTM
Verastem, Inc.
|
$7.70
|
$541.60M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.90
|
$540.97M | - | 47 | Compare |
|
MPLT
MPLT
|
$9.82
|
$535.19M | - | 47 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.99
|
$529.35M | 10.9 | 47 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$77.97
|
$522.78M | - | 57 | Compare |
More PHAT Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry